Adeno-Associated Virus (AAV) Gene Therapy Market
Adeno-Associated Virus (AAV) Gene Therapy Market - Global Industry Assessment & Forecast
#
Pages:
252
Base Year:
2023
Nov - 2024
Format:
Report Code:
VMR-3163
Segments Covered
By
Types Luxturna, Zolgensma, Others
-
By
Applications Central Nervous System Diseases, Ocular Diseases, Liver-directed Diseases, Other Hereditary Diseases
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD XX Million |
 Revenue 2032:
|
USD XX Million |
 Revenue CAGR
(2024 - 2032): |
XX |
Fastest Growing Region (2024 -
2032)
|
XX |
Largest Region (2023):
|
XX |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Adeno-Associated Virus (AAV) Gene Therapy Market Segment Analysis
- Adeno-Associated Virus (AAV) Gene Therapy Types Outlook (Revenue, USD Million, 2018 - 2030)
- Luxturna
- Zolgensma
- Others
- Adeno-Associated Virus (AAV) Gene Therapy Applications Outlook (Revenue, USD Million, 2018 - 2030)
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
-
North America Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- U.S.
- U.S. Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- U.S. Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- U.S. Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Canada
- Canada Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- Canada Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Canada Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
Mexico
- Mexico Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- Mexico Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Mexico Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
North America Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Europe
-
Europe Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
-
Europe Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- U. K.
- U.K. Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- U.K. Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- U.K. Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- France
- France Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- France Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- France Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
Germany
- Germany Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- Germany Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Germany Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
Italy
- Italy Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- Italy Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Italy Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
Spain
- Spain Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- Spain Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Spain Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
Rest of Europe
- Rest of Europe Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- Rest of Europe Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Rest of Europe Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
Europe Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Asia Pacific
-
Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
-
Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- China
- China Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- China Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- China Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Japan
- Japan Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- Japan Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Japan Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
Germany
- Germany Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- Germany Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Germany Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
India
- India Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- India Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- India Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
South Korea
- South Korea Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- South Korea Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- South Korea Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
South East Asia
- South East Asia Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- South East Asia Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- South East Asia Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
Rest of Asia Pacific
- Rest of Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- Rest of Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Rest of Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Latin America
-
Latin America Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
-
Latin America Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Brazil
- Brazil Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- Brazil Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Brazil Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Argentina
- Argentina Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- Argentina Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Argentina Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
Rest of Latin America
- Rest of Latin America Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- Rest of Latin America Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Rest of Latin America Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
Latin America Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Middle East & Africa
-
Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
-
Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- GCC Countries
- GCC Countries Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- GCC Countries Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- GCC Countries Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- South Africa
- South Africa Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- South Africa Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- South Africa Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- Luxturna
- Zolgensma
- Others
- Rest of Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Rest of Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
-
Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
- North America
FAQ
Frequently Asked Question
What is the global demand for Adeno-Associated Virus (AAV) Gene Therapy in terms of revenue?
-
The global Adeno-Associated Virus (AAV) Gene Therapy valued at USD XX Million in 2023 and is expected to reach USD XX Million in 2032 growing at a CAGR of XX.
Which are the prominent players in the market?
-
The prominent players in the market are Creative Biolabs,Affinia Therapeutics,Spark Therapeutics,AGC Biologics,StrideBio,SIRION Biotech,Neurophth Biotechnology,Belief BioMed,BiBo Biopharma Engineering Co., LTD.,Beihai Kangcheng,PackGene Biotech,Sarepta Therapeutics,Carbon BioSciences,Kelonia Therapeutics,Roche,Remedium Bio.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of XX between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Adeno-Associated Virus (AAV) Gene Therapy include
Which region accounted for the largest share in the market?
-
XX was the leading regional segment of the Adeno-Associated Virus (AAV) Gene Therapy in 2023.
